Volitionrx (VNRX) Return on Sales (2012 - 2025)

Volitionrx (VNRX) has 8 years of Return on Sales data on file, last reported at 0.69% in Q4 2025.

• For the quarter ending Q4 2025, Return on Sales fell 55.0% year-over-year to 0.69%; the trailing twelve-month figure through Dec 2025 stood at 0.04% (up 4.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales for Q4 2025 stood at 0.69%, down from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.05% in Q4 2021 and bottomed at 0.69% in Q4 2025.
• The 5-year median for Return on Sales is 0.0% (2025), against an average of 0.17%.
• The widest annual swing landed in 2021, when Return on Sales soared 19078 bps; it then sank 61 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.05% in 2021, then sank by 85 bps to 0.01% in 2022, then tumbled by 4654 bps to 0.36% in 2023, then surged by 60 bps to 0.14% in 2024, then sank by 388 bps to 0.69% in 2025.
• The last three Return on Sales figures came in at 0.69% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.

Peer Comparison